Victory Capital Management’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-179,570
| Closed | -$1.46M | – | 2490 |
|
|
2024
Q3 | $1.46M | Buy |
179,570
+175,040
| +3,864% | +$1.43M | ﹤0.01% | 1606 |
|
|
2024
Q2 | $60.6K | Buy |
4,530
+110
| +2% | +$1.47K | ﹤0.01% | 2347 |
|
|
2024
Q1 | $205K | Sell |
4,420
-34
| -0.8% | -$1.58K | ﹤0.01% | 2217 |
|
|
2023
Q4 | $301K | Buy |
4,454
+979
| +28% | +$66.2K | ﹤0.01% | 2125 |
|
|
2023
Q3 | $252K | Buy |
3,475
+47
| +1% | +$3.4K | ﹤0.01% | 2161 |
|
|
2023
Q2 | $255K | Buy |
3,428
+620
| +22% | +$46.1K | ﹤0.01% | 2146 |
|
|
2023
Q1 | $149K | Buy |
2,808
+79
| +3% | +$4.2K | ﹤0.01% | 2302 |
|
|
2022
Q4 | $184K | Buy |
2,729
+513
| +23% | +$34.7K | ﹤0.01% | 2282 |
|
|
2022
Q3 | $277K | Sell |
2,216
-1,761
| -44% | -$220K | ﹤0.01% | 2275 |
|
|
2022
Q2 | $379K | Sell |
3,977
-18
| -0.5% | -$1.72K | ﹤0.01% | 2166 |
|
|
2022
Q1 | $463K | Sell |
3,995
-4,476
| -53% | -$519K | ﹤0.01% | 2150 |
|
|
2021
Q4 | $2.82M | Buy |
+8,471
| New | +$2.82M | ﹤0.01% | 1455 |
|